申请人:Lee Wen-Yee
公开号:US10908162B2
公开(公告)日:2021-02-02
Embodiments are directed to methods of identifying a subject having prostate cancer or renal cell carcinoma; or prostate cancer risk assessment of a subject by determining level of at least one volatile organic compound from a sample from the subject where a significantly different level of the at least one volatile organic compound in the sample as compared to the level of the compound in a control sample is indicative of the presence of prostate cancer or renal cell carcinoma or low-risk prostate cancer or high-low prostate cancer in the subject.
本发明的实施方案涉及识别患有前列腺癌或肾细胞癌的受试者的方法;或通过确定受试者样本中至少一种挥发性有机化合物的水平来评估受试者的前列腺癌风险的方法,其中样本中至少一种挥发性有机化合物的水平与对照样本中该化合物的水平相比存在显著差异,则表明受试者存在前列腺癌或肾细胞癌或低风险前列腺癌或高风险前列腺癌。